January 28, 2023
1 minute read
Several clinicians will be honored at this year’s Tandem Conference. ASTCT and CIBMTR Transplant and Cell Therapy Conferences February 15-19 in Orlando.
Fred A.Perbaum, M.D. Received the 2023 ASTCT Lifetime Achievement Award.
Executive vice president of Fred Hutchinson Cancer Center and co-leader of the institution’s hematologic malignancies program, Applebaum has spent most of his career developing treatments for lymphoma, leukemia, and other blood cancers. have spent
He was lead author of the first publication demonstrating the efficacy of cryopreserved autologous bone marrow transplantation for lymphoma patients. He has also contributed to the development of new non-transplant therapies for hematologic malignancies.
The 2022 ASTCT Public Service Award recognizes the dedication and resilience of doctors, nurses, pharmacists and senior practitioners who continue to serve patients with blood disorders during the ongoing civil war in Ukraine.
Sergiy Klymenko, MD, PhD, When Sybiryna Korenkova, MD, I accept this award on behalf of all Ukrainian medical professionals.
Leslie Keene, MD, PhD, presents the E. Donnall Thomas Lecture, which is awarded to individuals who have made significant contributions to the advancement of knowledge about blood and bone marrow transplantation.
Keane is director of the Center for Stem Cell Transplantation at the Dana-Farber/Boston Children’s Cancer and Hematologic Disorders Center and Professor of Pediatrics at Harvard Medical School.
Keane’s talk is titled “Targeted GVHD: From Bench to Bedside to FDA.” Her lab studies to improve hematopoietic cell transplantation by understanding the molecular drivers of alloreactivity and controlling these pathways in hopes of inducing post-transplant immune tolerance. This section explains.
